Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 27, 2020 - Biohaven Pharmaceuticals announced the FDA approval of Nurtec ODT (rimegepant), for the acute treatment of migraine with or without aura in adults.
Return to publications